25-Hydroxylation of vitamin D in primary biliary cirrhosis

Lancet. 1977 Apr 2;1(8014):720-1. doi: 10.1016/s0140-6736(77)92166-3.

Abstract

The ability to 25-hydroxylate vitamin D was investigated in thirty-nine patients with symptomatic primary biliary cirrhosis (P.B.C.). In seven previously untreated patients serum-25-hydroxy-vitamin-D (25-OHD) concentration increased after regular monthly injections of vitamin D. After a single injection of vitamin D in eight P.B.C. patients serum-25-OHD did not change significantly over 12 days; in contrast there were significant increases in eight normal subjects and in seven patients with nutritional osteomalacia. Twenty-three of twenty-five P.B.C. patients on regular vitamin-D therapy had normal serum-25-OHD values. These results indicate that serum-25-OHD concentrations become normal in P.B.C. if adequate amounts of vitamin D are presented to the liver as substrate.

Publication types

  • Comparative Study

MeSH terms

  • Adult
  • Aged
  • Ergocalciferols / administration & dosage
  • Ergocalciferols / therapeutic use
  • Female
  • Follow-Up Studies
  • Humans
  • Hydroxycholecalciferols / blood
  • Hydroxycholecalciferols / metabolism*
  • Injections, Intramuscular
  • Liver / metabolism
  • Liver Cirrhosis, Biliary / blood
  • Liver Cirrhosis, Biliary / complications
  • Liver Cirrhosis, Biliary / metabolism*
  • Male
  • Middle Aged
  • Osteomalacia / complications
  • Osteomalacia / metabolism
  • Vitamin D Deficiency / drug therapy
  • Vitamin D Deficiency / etiology

Substances

  • Ergocalciferols
  • Hydroxycholecalciferols